Comparing AOD-9604 to FDA-Approved Alternatives for Weight Management Virginia patients who are interested in AOD-9604 for body-fat reduction should understand where it sits relative to approved options
The FDA mandates that peptide manufacturers follow good manufacturing practices (GMPs) and conduct clinical trials to demonstrate the safety and efficacy of their products
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that plays a central role in NAD+ metabolism and cellular energy balance
May your fat cells stay responsive, your lean mass stay protected, and your protocols stay evidence-based.
This product has not been evaluated or approved by the FDA and is not for human or animal use
Standard AOD-9604 Dosing : Dose: 0.20.3 mg per injection Frequency: Once or twice daily Timing: Morning: Ideally before fasted cardio or 12 hours before breakfast Evening: 13 hours after dinner, before bedtime Targeting Fat Loss Inject into areas with stubborn fat (e.g., abdomen, thighs) Best results occur when combined with exercise and a clean diet Cycle Duration : Loading Phase: 46 weeks of daily use Maintenance Phase: 23 injections per week to sustain results Breaks: Optional 12 week breaks every few months to avoid receptor desensitization Why Timing Matters : Administering AOD-9604 on an empty stomach enhances absorption Pairing with fasted cardio may amplify lipolytic effects Side Effects to Watch For : Mild nausea Headaches Localized irritation at injection site These are rare and typically resolve quickly